If you’re considering GLP-1 therapy in Fort Worth, you probably have one question that matters more than anything else: how much weight will you actually lose?
The short answer is that most patients lose between 10 to 20 pounds in their first 90 days. Some lose more, while a few others lose less. It varies per individual, and what ultimately determines your results is unique factors like the quality of your program, the consistency of your injections, and how your lifestyle supports the medication.
At InjectCo in Fort Worth, our nurse-led GLP-1 program uses compounded semaglutide to help patients lose weight in a way that is safe, supervised, and built for real life situations. Here’s exactly what you can expect in the first 90 days.
Semaglutide belongs to a class of medications called GLP-1 receptor agonists. GLP-1 stands for glucagon-like peptide-1, a hormone your body naturally releases after eating food. When semaglutide mimics this hormone, it signals to your brain that you are full, slows the rate at which food leaves your stomach, and helps stabilize blood sugar levels.
The result is that you eat less without fighting constant hunger, in which cravings quiet down and food portions shrink naturally as your body starts burning stored fat for energy.
Semaglutide is the active ingredient found in brand-name medications like Ozempic and Wegovy. At InjectCo, we offer compounded semaglutide, which delivers the same active ingredient at a fraction of the brand cost and is available for delivery anywhere in Texas.
Let’s take a closer look at the 90-day results timeline on a monthly basis:
Most patients notice hunger suppression within the first week of their first injection. This is when food cravings start to feel less urgent and portions naturally shrink. Weight loss in month one is typically 2 to 5 pounds. Your body starts adjusting to the medication, and appetite changes almost always show up before the scale does. Patients often describe feeling more in control around food than they have in years.
By weeks 4 to 8, most patients have moved through the initial dose adjustment phase. With a higher dose maintaining consistent medication levels, appetite suppression deepens and weight loss accelerates.
A typical month two brings 4 to 8 additional pounds of weight loss. Food noise or cravings continue to decrease, and energy improves. Patients who combine their injections with modest dietary changes tend to see the strongest results at this stage.
By the 90-day mark, most InjectCo patients on a medically supervised semaglutide program have lost 10 to 20 pounds. A real-world study published in the journal Advances in Therapy found that patients enrolled in a supervised semaglutide program averaged 13.4% total body weight loss by six months, with over 70% losing more than 5% of their body weight within the first three months.
Put in real, practical terms: a 180-pound patient losing 5% in 90 days loses 9 pounds. A patient at 220 pounds losing 10% in that same window loses 22 pounds. Both outcomes are realistic on a medically supervised program.
Not every patient loses weight at the same rate, and this is normal. Several factors influence how quickly semaglutide works for you.
Our lead nurse injector, Kiara DeWitt, BSN RN, CPN, brings clinical experience from the neurosurgery and neurology unit at Cook Children’s Hospital alongside her TCU nursing background. Her level of clinical training and expertise shape how we manage each patient’s program, from initial dosing through ongoing adjustments.
Brand-name GLP-1 medications like Ozempic and Wegovy are expensive and frequently unavailable due to insurance restrictions and ongoing supply issues. Compounded semaglutide, on the other hand, contains the same active ingredient and is often prescribed by a licensed provider, but without the brand-name pricing or insurance hurdles.
At InjectCo, our compounded semaglutide program is administered under the supervision of a licensed physician and is available for delivery anywhere in Texas. For patients in Fort Worth, the program includes an initial consultation, customized dosing, and ongoing check-ins to monitor progress and adjust as needed. If clinically appropriate, compounded medication may be prescribed as part of your program and sourced from a licensed 503B pharmacy.
To learn more about our Fort Worth GLP-1 program and whether you’re a good candidate, visit our semaglutide weight loss program page for Fort Worth, TX.
Semaglutide is typically recommended for adults with a BMI of 27 or higher who have a weight-related health condition, or adults with a BMI of 30 or higher regardless of other conditions.
Patients who are pregnant or breastfeeding, or who have a personal or family history of medullary thyroid cancer or MEN2 syndrome, are not viable candidates. A brief medical intake at InjectCo reviews your history and confirms whether you’re a good fit before any prescription is issued.
If you’re ready to start or want to know if semaglutide makes sense for your situation, our nurse-led Fort Worth team is here to help.
InjectCo MedSpa in Fort Worth serves patients across West Fort Worth, Lake Worth, Benbrook, White Settlement, and other surrounding areas or communities. Our nurse-led GLP-1 program starts with a straightforward evaluation and consultation so we can confirm if you’re a candidate and build your dosing plan before your first injection. Call us at (817) 285-5254 or schedule your Fort Worth semaglutide consultation online.
Most patients lose between 10 and 20 pounds in their first 90 days on a supervised semaglutide program. Results vary based on starting weight, dose compliance, and lifestyle factors. Patients with a higher starting weight tend to see larger early losses. A real-world study found that over 70% of patients lost more than 5% of their body weight within the first three months of their supervised semaglutide treatment.
Most patients notice reduced appetite within the first week of their first injection. Measurable weight loss typically begins by weeks 3 to 4. The first month is primarily about your body adjusting to the medication. Weight loss accelerates in months 2 and 3 as the dose increases.
Compounded semaglutide contains the same active ingredient as brand-name GLP-1 medications. It is prescribed and supervised by a licensed provider. The primary differences are cost and accessibility. Compounded versions are not subject to brand-name pricing or insurance requirements, making the program more accessible for patients who are not covered or who face supply shortages.
The patients who see the best results on semaglutide are consistent with their weekly injections, eat a protein-forward diet, stay hydrated, and get regular movement even if it is light. You do not need a perfect diet or an intense workout routine, but the medication responds to effort. Regular check-ins with your provider also help ensure your dose is optimized for your response.
Yes. InjectCo MedSpa is located at 4701 West Freeway Suite 152 in Fort Worth, inside Mattison Ave Suites at the Chapel Hill Shopping Center. We offer both in-person and online consultations for patients across Texas who prefer to receive their compounded semaglutide by delivery. Call (817) 285-5254 to schedule.
Clinical and real-world data suggest that most adults lose between 10 and 20 pounds in the first 90 days on a GLP-1 program. A real-world study published in Advances in Therapy found an average of 13.4% total body weight loss at six months in a supervised semaglutide program, with significant early progress in the first three months. Results depend on starting weight, dose consistency, and lifestyle support.
Weeks 1 to 4: Appetite suppression begins, weight loss of 2 to 5 pounds as the body adjusts. Weeks 4 to 8: Dose increases, appetite suppression deepens, 4 to 8 additional pounds typical. Weeks 8 to 12: Steady fat loss with 10 to 20 pounds total lost for most patients. Weeks 12 onward: Continued progress with the potential for 15% or more total body weight loss by 6 months for patients who stay on program.
Yes, semaglutide produces weight loss without requiring structured exercise. However, patients who add regular movement, even walking 20 to 30 minutes per day, see faster results and better long-term outcomes. Exercise helps preserve muscle mass during weight loss and improves metabolic health, which can extend and enhance the benefits of GLP-1 therapy.
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows digestion. Tirzepatide works on two hormone receptors, GLP-1 and GIP, which can accelerate early weight loss for some patients. Tirzepatide often produces faster initial results, while semaglutide is typically better tolerated for patients who are sensitive to medications. A licensed provider can help determine which option is better suited to your health history and weight loss goals.
Semaglutide continues to work as long as you are taking it consistently. Most patients see steady progress for 6 to 12 months. Weight loss typically slows after reaching a new set point, which is a normal plateau and not a sign the medication has stopped working. Dosage adjustments and lifestyle modifications can help patients continue progressing. Studies show continued weight loss at 18 and 24 months for patients who stay on a supervised program.
